Associated Papers
The molecular spectrum of Turkish osteopetrosis and related osteoclast disorders with natural history, including a candidate gene, CCDC120.
Tüysüz B et al.
Bone, 2023
Genetic disorders associated with the RANKL/OPG/RANK pathway.
Xue JY et al.
Journal of Bone and Mineral Metabolism, 2021
Osteopetrosis: genetics, treatment and new insights into osteoclast function.
Sobacchi C et al.
Nature Reviews. Endocrinology, 2013
RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations.
Pangrazio A et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2012
New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.
Crockett JC et al.
Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa, 2011
Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis.
Ta HM et al.
Proceedings of the National Academy of Sciences of the United States of America, 2010
Structural and functional insights of RANKL-RANK interaction and signaling.
Liu C et al.
Journal of Immunology (baltimore, Md. : 1950), 2010
Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.
Guerrini MM et al.
American Journal of Human Genetics, 2008
Select a paper to view details